Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Emeritus Professor Philip Home
Newcastle Authors
Title
Year
Full text
Emeritus Professor Philip Home
How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?
2020
Emeritus Professor Philip Home
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
2020
Emeritus Professor Philip Home
Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: A randomized trial
2020
Emeritus Professor Philip Home
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis
2020
Emeritus Professor Philip Home
Is Insulin Therapy Safe?
2020
Emeritus Professor Philip Home
Tackling obesity during the COVID-19 pandemic
2020
Emeritus Professor Philip Home
Cardiovascular outcome trials of glucose-lowering medications: an update
2019
Emeritus Professor Philip Home
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
2019
Emeritus Professor Philip Home
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground
2019
Emeritus Professor Philip Home
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program
2019
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...